← Back to Screener
Canopy Growth Corporation Common Shares (CGC)
Price$1.15
Favorite Metrics
Price vs S&P 500 (26W)-27.84%
Price vs S&P 500 (4W)10.66%
Market Capitalization$491.38M
All Metrics
Book Value / Share (Quarterly)$1.50
P/TBV (Annual)0.70x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-19.22%
Cash Flow / Share (Quarterly)$-0.17
Price vs S&P 500 (YTD)2.24%
Gross Margin (TTM)26.56%
Net Profit Margin (TTM)-117.31%
EPS (TTM)$-1.35
10-Day Avg Trading Volume1.75M
EPS Excl Extra (TTM)$-1.35
Revenue Growth (5Y)-7.57%
EPS (Annual)$-4.06
ROI (Annual)-73.62%
Gross Margin (Annual)30.30%
Net Profit Margin (5Y Avg)-327.43%
Cash / Share (Quarterly)$0.74
Revenue Growth QoQ (YoY)-0.29%
ROA (Last FY)-65.18%
Revenue Growth TTM (YoY)0.59%
EBITD / Share (TTM)$-0.29
ROE (5Y Avg)-143.17%
Operating Margin (TTM)-30.71%
Cash Flow / Share (Annual)$-0.70
P/B Ratio0.89x
P/B Ratio (Quarterly)0.77x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.00x
Net Interest Coverage (TTM)-0.29x
ROA (TTM)-32.67%
EV / EBITDA (TTM)116.13x
EPS Incl Extra (Annual)$-4.06
Current Ratio (Annual)3.12x
Quick Ratio (Quarterly)4.21x
3-Month Avg Trading Volume3.35M
52-Week Price Return12.59%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.35
P/S Ratio (Annual)2.50x
Asset Turnover (Annual)0.29x
52-Week High$3.28
Operating Margin (5Y Avg)-253.07%
EPS Excl Extra (Annual)$-4.06
CapEx CAGR (5Y)-56.47%
Tangible BV CAGR (5Y)-38.24%
26-Week Price Return-24.06%
Quick Ratio (Annual)2.04x
13-Week Price Return-6.94%
Total Debt / Equity (Annual)0.67x
Current Ratio (Quarterly)5.34x
Enterprise Value$406.618
Revenue / Share Growth (5Y)16.89%
Asset Turnover (TTM)0.28x
Book Value / Share Growth (5Y)-28.39%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.16x
Pretax Margin (Annual)-221.94%
Cash / Share (Annual)$0.52
3-Month Return Std Dev52.11%
Gross Margin (5Y Avg)0.76%
Net Income / Employee (TTM)$-0
ROE (Last FY)-122.76%
Net Interest Coverage (Annual)-0.34x
EPS Basic Excl Extra (Annual)$-4.06
Receivables Turnover (TTM)7.59x
Total Debt / Equity (Quarterly)0.34x
EPS Incl Extra (TTM)$-1.35
Receivables Turnover (Annual)5.82x
ROI (TTM)-35.91%
P/S Ratio (TTM)2.42x
Pretax Margin (5Y Avg)-315.56%
Revenue / Share (Annual)$1.82
Tangible BV / Share (Annual)$1.59
Price vs S&P 500 (52W)-17.48%
Year-to-Date Return3.21%
5-Day Price Return7.33%
EPS Normalized (Annual)$-4.06
ROA (5Y Avg)-56.25%
Net Profit Margin (Annual)-222.35%
Month-to-Date Return21.97%
Cash Flow / Share (TTM)$-1.32
EBITD / Share (Annual)$-0.73
Operating Margin (Annual)-35.24%
LT Debt / Equity (Annual)0.62x
ROI (5Y Avg)-64.29%
LT Debt / Equity (Quarterly)0.30x
EPS Basic Excl Extra (TTM)$-1.35
P/TBV (Quarterly)0.86x
P/B Ratio (Annual)0.57x
Inventory Turnover (TTM)2.08x
Pretax Margin (TTM)-117.14%
Book Value / Share (Annual)$1.93
Price vs S&P 500 (13W)-6.99%
Beta2.07x
Revenue / Share (TTM)$0.59
ROE (TTM)-52.88%
52-Week Low$1.18
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
2.38
2.38
2.38
2.38
Industry Peers — Pharmaceutical Preparations(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
CGCCanopy Growth Corporation Common Shares | 2.42x | 0.59% | 26.56% | — | $1.15 |
CRONCronos Group Inc. Common Share | 7.06x | 24.63% | 42.81% | -49.98% | $2.68 |
TLRYTilray Brands, Inc. Common Stock | 0.92x | 3.82% | 27.68% | — | $6.79 |
NAGENiagen Bioscience, Inc. Common Stock | 2.93x | 29.95% | 64.28% | — | $4.73 |
USNAUSANA Health Sciences Inc | 0.38x | 5.88% | 78.29% | -37.04% | $19.06 |
SNDLSundial Growers Inc. Common Shares | 0.58x | 2.82% | 27.33% | — | $1.51 |
MDWDMediWound Ltd. | 13.10x | -16.14% | 19.19% | — | $17.10 |
ACBAurora Cannabis Inc. Common Shares | 0.78x | 16.54% | 1.35% | — | $3.61 |
FTLFFitLife Brands, Inc. Common Stock | 1.34x | 1.34% | 37.58% | -20.04% | $9.25 |
BTMDBiote Corp. Class A Common Stock | 0.41x | -2.52% | 71.46% | -26.84% | $2.10 |
NAIINatural Alternatives International Inc. | 0.12x | 10.92% | 9.06% | — | $2.69 |
About
Canopy Growth is a diversified cannabis producer offering medicinal and recreational products through a portfolio of brands including Doja, LivRelief, Ace Valley, and Deep Space. The company operates across four segments: Canadian cannabis (its primary revenue source), international markets, Storz & Bickel vaporizers, and This Works wellness products.